In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity

F Santini1, P Vitti, G Ceccarini

  • 1Department of Endocrinology, Centro di Eccellenza AmbiSEN, University of Pisa, Pisa, Italy. fsantini@endoc.med.unipi.it

Insights

This study developed in vitro assays to identify thyroid disruptors. Melissa Officinalis, DDT, and Aroclor 1254 were found to inhibit TSH-stimulated cAMP production through different mechanisms.

Area of Science:

  • Endocrinology
  • Toxicology
  • Cell Biology

Background:

  • Chemicals can disrupt thyroid function, necessitating reliable testing methods.
  • In vitro assays are crucial for assessing thyroid-disrupting potential.
  • 12 suspected thyroid disruptors were evaluated for their impact on TSH-stimulated cAMP production.

Purpose of the Study:

  • To develop and utilize in vitro assays to investigate thyroid disruptor mechanisms.
  • To determine how specific chemicals interfere with TSH-mediated cAMP signaling.
  • To differentiate between pre-receptor and post-receptor mechanisms of action.

Main Methods:

  • Utilized Chinese hamster ovary (CHO) cells transfected with the human TSH receptor.
  • Assessed inhibition of TSH-stimulated cAMP production and adenylate cyclase activity.
  • Investigated TSH binding to its receptor and antibody binding to TSH.

Main Results:

  • DDT, Aroclor 1254, and Melissa Officinalis inhibited TSH-stimulated cAMP production.
  • Melissa Officinalis inhibited TSH binding and antibody binding to TSH.
  • DDT and Aroclor 1254 primarily affected post-receptor signaling pathways.

Conclusions:

  • Developed in vitro assays to analyze thyroid disruptor effects on the cAMP cascade.
  • Identified distinct mechanisms of action for Melissa Officinalis, DDT, and Aroclor 1254.
  • These assays support animal and epidemiological studies in thyroid disruptor research.

Related Concept Videos